RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Patience is a pre-requisite in the OTC for the most spectacular gains. Traders typically flip out early for merely a few ticks or fail to hold winners. How many stories just on this board of selling other pharmas right before that 50-100 fold rise!!

Combining PR and recent CEO interview it is both logical and likely they are currently pursuing JV/partnering with BP to open “purse strings” now to further the pain/epilepsy candidate and likely could see multiple paths or deals borne out of that substantial progress.

My perception is the tier 3 NIH trials are probably the final piece to determine how valuable the candidate is. Is the potential heading into human clinical trials “somewhat” promising or “confidently optimistic” better medication is in the works…

As discussed, this sneezes anything positive and it can run multi penny overnight. A significant BP deal can have this trading for nickels, dimes or more…

Alas patience can also be frustrating….